The increasing prevalence of chronic and hospital-acquired infections produced by
multidrug-resistant (MDR) or extensively drug-resistant (XDR) Pseudomonas aeruginosa …

Chronic lower airway infection with Pseudomonas aeruginosa is a major contributor to
morbidity and mortality in individuals suffering from the genetic disease cystic fibrosis (CF) …

Small colony variants (SCVs) were first described more than 100 years ago for
Staphylococcus aureus and various coagulase-negative staphylococci. Two decades ago …

Introduction: Pseudomonas aeruginosa infections are prevalent amongst chronic
rhinosinusitis (CRS) sufferers. Many P. aeruginosa strains form biofilms, leading to treatment …

Pseudomonas aeruginosa is a remarkably versatile environmental bacterium with an
extraordinary capacity to infect the cystic fibrosis (CF) lung. Infection with P. aeruginosa …

The first step in bacteriophage infection is recognition and binding to the host receptor,
which is mediated by the phage receptor binding protein (RBP). Different RBPs can lead to …

Pseudomonas is a ubiquitous genus that also causes human, animal and plant diseases.
Most studies have focused on clinical P. aeruginosa strains from humans, but they are …

Highlights•Pseudomonas aeruginosa in CF airways: paradigm of bacterial microevolution.•
Evolution within CF host triggers conversions of genotype and phenotype.•Severity of lung …

Cystic fibrosis (CF) is a complex inherited disease which affects many organs, including the
pancreas and liver, gastrointestinal tract and reproductive system, sweat glands and …

Pseudomonas aeruginosa is a major opportunistic pathogen in cystic fibrosis (CF) patients
and causes a wide range of infections among other susceptible populations. Its inherent …